Trial Profile
IntraCoronary Treatment With Integrilin [eptifibatide] To Improve ANgiographic Outcomes (IC TITAN - TIMI 47) Trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary)
- Indications Coronary thrombosis
- Focus Therapeutic Use
- Acronyms IC-TITAN
- 12 Aug 2008 New trial record.